Physician

Habteab Betsuamlac Feseha, M.D.

According to 2025 Medicare claims, Habteab Feseha, M.D. (NPI: 1679665517) practices interventional cardiology in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is RED SEA HEART CENTER PLC (NPI: 1649463506; TIN: 260391172) and primary practice location at 85364-8011.

Feseha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 949 traditional Medicare patients, billed 3,960 HCPCS/CPT codes, and received $320,269 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,453 prescription claims across 1,026 beneficiaries totaling $878,213 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 32 records totaling $2,087. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $429,642 and ending at $320,269. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $155,521 to $878,213. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,335	6,548	$429,642
2016	1,223	6,093	$555,217
2017	1,178	5,433	$508,225
2018	1,153	5,055	$490,105
2019	1,321	5,502	$529,432
2020	1,029	4,740	$313,918
2021	891	4,268	$311,862
2022	1,100	5,558	$487,044
2023	1,085	5,081	$453,625
2024	949	3,960	$320,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	646	5,165	$155,521
2016	731	5,825	$181,799
2017	780	5,695	$229,705
2018	761	5,094	$283,825
2019	860	5,532	$423,579
2020	957	6,571	$597,084
2021	945	6,514	$662,944
2022	972	6,424	$710,063
2023	960	6,151	$848,361
2024	1,026	6,453	$878,213

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	101	101	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	621	1,053	$83
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	337	352	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	239	322	$61
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	192	213	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	348	24,202	$442,243
Entresto	Sacubitril/Valsartan	124	7,530	$154,580
Xarelto	Rivaroxaban	57	3,308	$59,217
Brilinta	Ticagrelor	18	1,440	$20,734
Jardiance	Empagliflozin	13	1,170	$20,536

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$2,087	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Habteab Betsuamlac Feseha, M.D.?

Tedicare shows public-source Medicare data for Habteab Betsuamlac Feseha, M.D. (NPI 1679665517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Habteab Betsuamlac Feseha, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Habteab Betsuamlac Feseha, M.D.?

Habteab Betsuamlac Feseha, M.D. is linked to RED SEA HEART CENTER PLC (billing NPI 1649463506) in the available physician profile data.

Does Habteab Betsuamlac Feseha, M.D. have Open Payments data?

Habteab Betsuamlac Feseha, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.